Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:53:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH announcement appears at the top of the page, explaining that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    0.8%
    Check dated 2026-10-25T14:55:37.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T15:15:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:08:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new version entry (v3.7.0) was added to the study record history, while the previous version (v3.6.6) was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-20T11:22:14.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Adds Revision: v3.6.6 to the study record history and removes Revision: v3.6.5, reflecting an update to the record's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-29T23:53:50.000Z thumbnail image

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.